Cordifolioside: potent inhibitor against M(pro) of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α

Therapeutic options for SARS-CoV-2 are limited merely to the symptoms or repurposed drugs and non-specific interventions to promote the human immune system. In the present study, chromatographic and in silico approaches were implemented to identify bioactive compounds which might play pivotal role a...

Descripción completa

Detalles Bibliográficos
Autores principales: Manne, Munikumar, Goudar, Giridhar, Varikasuvu, Seshadri Reddy, Khetagoudar, Mahadev C., Kanipakam, Hema, Natarajan, Pradeep, Ummiti, Muni Divya, Yenagi, Vijay Aravind, Chinthakindi, Sridhar, Dharani, Prakash, Thota, Durga Sai Sri, Patil, Sameer, Patil, Vijaylaxmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898013/
https://www.ncbi.nlm.nih.gov/pubmed/33643762
http://dx.doi.org/10.1007/s13205-021-02685-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898013/
https://www.ncbi.nlm.nih.gov/pubmed/33643762
http://dx.doi.org/10.1007/s13205-021-02685-z

Ejemplares similares